S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
Log in
NASDAQ:AMED

Amedisys Short Interest Ratio and Short Volume

$235.18
+3.88 (+1.68 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$231.45
Now: $235.18
$238.54
50-Day Range
$231.30
MA: $249.66
$268.56
52-Week Range
$132.95
Now: $235.18
$273.77
Volume109,364 shs
Average Volume268,782 shs
Market Capitalization$7.72 billion
P/E Ratio47.13
Dividend YieldN/A
Beta0.9

Short Interest

Amedisys (NASDAQ:AMED) Short Interest Data

Current Short Volume:461,800 shares
Previous Short Volume:506,400 shares
Change Vs. Previous Month:-8.81%
Dollar Volume Sold Short:$112.42 million
Short Interest Ratio / Days to Cover:3.0
Last Record Date:October, 30 2020
Outstanding Shares:32,050,000 shares
Short Percent of Float:0.00%
Today's Trading Volume:109,364 shares
Average Trading Volume:268,782 shares
Today's Volume Vs. Average:-59.31%



Amedisys (NASDAQ:AMED) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
10/30/2020461,800 $112.42 million -8.8%0.0%2.6$243.43
10/15/2020506,400 $129.44 million 28.4%1.6%2.8$255.61
9/30/2020394,500 $99.49 million -6.3%1.2%2$252.19
9/15/2020420,900 $97.81 million -32.4%1.3%1.5$232.38
8/31/2020623,000 $142.64 million -12.4%2.0%1.9$228.95
8/14/2020710,900 $171.88 million -12.1%2.2%2$241.78
7/31/2020808,800 $189.71 million -12.7%2.5%2.2$234.56
7/15/2020926,200 $216.88 million -24.1%2.9%2.4$234.16
6/30/20201,220,000 $261.98 million 14.0%3.8%3$214.74
6/15/20201,070,000 $221.35 million -10.8%3.4%3.3$206.87
5/29/20201,200,000 $230.40 million 8.1%3.8%3.8$192.00
5/15/20201,110,000 $213.18 million 0.0%3.5%3.5$192.05
4/30/20201,110,000 $203.01 million -8.3%3.5%3.5$182.89
4/15/20201,210,000 $215.42 million 4.3%3.8%4.2$178.03
3/31/20201,160,000 $216.34 million 3.8%3.7%4.3$186.50
3/13/20201,117,200 $214.38 million 6.4%3.5%3.8$191.89
2/28/20201,050,000 $176.61 million -5.4%3.3%4.7$168.20
2/14/20201,110,000 $194.33 million -11.2%3.5%5.2$175.07
1/31/20201,250,000 $236.09 million 5.9%3.9%6.3$188.87
1/15/20201,180,000 $230.25 million -7.8%3.7%5$195.13
12/31/20191,280,000 $229.09 million -3.0%4.0%5.4$178.98
8/15/20191,610,700 $209.54 million -2.2%5.1%4.5$130.09

Amedisys (NASDAQ:AMED) Short Interest FAQ

speech bubbles
speech bubbles











What is Amedisys' current short interest?

Short interest is the volume of Amedisys shares that have been sold short but have not yet been covered or closed out. As of October 30th, traders have sold 461,800 shares of AMED short. 0.00% of Amedisys' shares are currently sold short. View details.

What is a good short interest ratio for Amedisys?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Amedisys currently has a short interest ratio of 3.0.

Is Amedisys' short interest increasing or decreasing?

Amedisys saw a drop in short interest during the month of October. As of October 30th, there was short interest totaling 461,800 shares, a drop of 8.8% from the previous total of 506,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Amedisys' short interest compare to its competitors?

0.00% of Amedisys' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "health care services" compare to Amedisys: Laboratory Co. of America Holdings (1.75%), Quest Diagnostics Incorporated (1.50%), DaVita Inc. (4.88%), Chemed Co. (1.09%), LHC Group, Inc. (2.05%), AMN Healthcare Services, Inc. (3.09%), R1 RCM Inc. (0.00%), The Providence Service Co. (0.00%), MEDNAX, Inc. (11.45%), and CorVel Co. (2.78%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.66 billion), Aon Plc ($3.83 billion), Analog Devices, Inc. ($3.33 billion), ViacomCBS Inc. ($3.13 billion), Snap Inc. ($3.05 billion), The Clorox Company ($2.85 billion), Uber Technologies, Inc. ($2.80 billion), Moderna, Inc. ($2.26 billion), Simon Property Group, Inc. ($2.02 billion), and International Flavors & Fragrances Inc. ($1.96 billion). View all of the most shorted stocks.

What does it mean to sell short Amedisys stock?

Short selling AMED is an investing strategy that aims to generate trading profit from Amedisys as its price is falling. Amedisys' stock is trading up $3.88 today. To short Amedisys stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Amedisys will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Amedisys?

A short squeeze for Amedisys occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AMED, which in turn drives the price of the stock up even further.

How often is Amedisys' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMED, twice per month. The most recent reporting period available is October, 30 2020.


This page was last updated on 11/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.